IV-275
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No
IV-275
Target :
Epigenetic Reader DomainRelated Pathways :
Chromatin/EpigeneticBioactivity :
IV-275 is a dual inhibitor targeting the bromodomains of both BRG1 and BRM. This compound not only augments DNA damage when combined with Temozolomide and Bleomycin but also suppresses the invasiveness of GBM cells. Furthermore, IV-275 amplifies Temozolomide-induced cell death and its apoptosis-inducing activity [1].Molecular Formula :
C19H18F2N2O3Molecular Weight :
360.35Shipping Conditions :
Cool packStorage Temperature :
-20°C
